The Pharmacogenetic Variability Associated With the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study

拜瑞妥 医学 药代动力学 药效学 药物遗传学 药理学 单核苷酸多态性 基因型 内科学 肿瘤科 基因 华法林 遗传学 生物 心房颤动
作者
Zhiyan Liu,Qiufen Xie,Xia Zhao,Yunlong Tan,Wenping Wang,Yu Cao,Xiaohua Wei,Guangyan Mu,Hanxu Zhang,Shuang Zhou,Xiaobin Wang,Ying Cao,Xin Li,Song Chen,Duanwen Cao,Yimin Cui,Qian Xiang
出处
期刊:Clinical Therapeutics [Elsevier BV]
标识
DOI:10.1016/j.clinthera.2024.02.009
摘要

Abstract

Purpose

This study aimed to explore the pharmacogenetic variability associated with the pharmacokinetics (PK) and pharmacodynamics (PD) of rivaroxaban in healthy Chinese subjects.

Methods

This was a multicenter study that included 304 healthy adults aged 18 to 45 years with unknown genotypes. All participants were administered a single dose of rivaroxaban at 10 mg, 15 mg, or 20 mg. PK and PD parameters were measured, and exome-wide association analysis was conducted.

Findings

Sixteen SNPs located on 11 genes influenced the AUC0-t. Among these, the 3 most influential genes were MiR516A2, PARP14, and MIR618. Thirty-six SNPs from 28 genes were associated with the PD of rivaroxaban. The 3 most influential genes were PKNOX2, BRD3, and APOL4 for anti-Xa activity, and GRIP2, PLCE1, and MLX for diluted prothrombin time (dPT). Among them, BRD3 played an important role in both the PK and PD of rivaroxaban. Anti-Xa activity (ng/mL) differed significantly among subjects with BRD3 rs467387: 145.1 ± 55.5 versus 139.9 ± 65.1 versus 164.0 ± 68.6 for GG, GA, and AA carriers, respectively (P = 0.0002).

Implications

This study found that that the regulation of the BRD3 gene might affect the PK and PD of rivaroxaban, suggesting that it should be studied as a new pharmacologic target. The correlation between this gene locus and clinical outcomes has yet to be verified in patients undergoing clinical treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
达斯维完成签到,获得积分10
刚刚
Akim的应助被科研通管家采纳,获得10
1秒前
艾妮吗发布了新的文献求助10
1秒前
DW的应助被科研通管家采纳,获得10
1秒前
田様的应助被科研通管家采纳,获得30
1秒前
星辰大海的应助被科研通管家采纳,获得10
1秒前
后笑晴发布了新的文献求助10
1秒前
李爱国的应助被科研通管家采纳,获得10
1秒前
隐形曼青的应助被科研通管家采纳,获得50
1秒前
null的应助被科研通管家采纳,获得10
1秒前
赘婿的应助被正直未来采纳,获得10
1秒前
Akim的应助被科研通管家采纳,获得10
2秒前
Owen的应助被岂有此栗采纳,获得30
2秒前
桐桐的应助被科研通管家采纳,获得10
2秒前
爆米花的应助被科研通管家采纳,获得10
2秒前
李健的应助被科研通管家采纳,获得10
2秒前
2秒前
bkagyin的应助被兖州牧采纳,获得10
2秒前
Akim的应助被科研通管家采纳,获得10
2秒前
李健的应助被科研通管家采纳,获得10
2秒前
2秒前
秋风的应助被科研通管家采纳,获得20
3秒前
Ava的应助被科研通管家采纳,获得10
3秒前
完美世界的应助被xz采纳,获得50
3秒前
3秒前
3秒前
3秒前
Cr的应助被科研通管家采纳,获得10
3秒前
3秒前
Jasper的应助被科研通管家采纳,获得10
3秒前
Cr的应助被科研通管家采纳,获得10
3秒前
爆米花的应助被科研通管家采纳,获得10
3秒前
飞远完成签到,获得积分10
4秒前
5秒前
暴龙战神完成签到,获得积分10
5秒前
5秒前
6秒前
6秒前
6秒前
英俊的铭的应助被有魅力访曼采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485